STShaw-Jenq Tsai

Shaw-Jenq Tsai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shaw-Jenq Tsai has a total of 369 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • CARM1 orchestrates hypoxia-mediated chemoresistance through the H3R17me2a/FUS upregulation in colorectal cancer

    by Jhao-Lin Fu, Shih-Chieh Lin, Pei-Ling Hsu, Tzu-Chien Lin, Yu-Jing Tai, Kai-Li Chang, Yu-Ting Ko, Bo-Wen Lin, Shaw-Jenq Tsai

  • Interleukin-17A as a key driver for cell migration, proliferation, inflammation, and nerve infiltration in deep endometriosis

    by Hsiao-Chien Tang, Wan-Ning Li, Tin-Chien Lin, Meng-Hsing Wu, Chung-Hsien Sun, Shaw-Jenq Tsai

    In brief: Deep endometriosis is a highly invasive and severely painful disorder. This study identifies interleukin-17A as a central mediator that links immune-driven inflammation to the acquisition of pathogenic behaviors, including proliferation, invasion, and nerve infiltration, thereby the aggressive and pain-associated phenotypes of deep endometriosis. Deep endometriosis (DE) is the most severe subtype of endometriosis, marked by aggressive cellular behavior and debilitating pain. However, the molecular mechanisms underlying DE pathogenesis remain poorly understood. In this study, we identified interleukin (IL)-17A as a critical mediator driving the pathological processes of DE. The level of IL-17A was elevated in DE tissues, with T cells, mast cells, macrophages, and endometriosis stromal cells as sources of IL-17A. Functional assays demonstrated that IL-17A stimulates the proinflammatory cytokines such as IL-1β and IL-6 as well as enhancing the proliferative and migratory capacities through activation of ERK1/2 and Notch1 signaling pathways. Immunohistochemical (IHC) staining further revealed that levels of NICD and Ki67 are abundant and positively correlates with each other in DE lesions. In addition, PGP9.5+ nerves bundles are evidently detected in DE tissues as compared with normal endometria, pelvic endometriotic lesions, and ovarian endometrioma, which reflects the nature of severe pain in DE patients. Treatment with IL-17A induces the expression of nerve growth factor (NGF), a peptide growth factor to induce nerve infiltration. The IHC staining revealed a significant positive correlation between PGP9.5+ nerves and NGF signals specifically in DE lesions. Collectively, these findings suggest that IL-17A promotes DE lesion progression by sustaining chronic inflammation and enhancing endometrial stromal cells proliferation, migration, and nerve infiltration, thereby contributing to inflammation-associated neuropathic pain in affected patients.

  • Hypoxia-induced miR-21-5p promotes autophagy by downregulating CDC25A in endometriosis

    by Huan-Tzu Hou, Ya-Chuan Tsai, Shih-Chieh Lin, Po-Hung Pan, Meng-Hsing Wu, Shaw-Jenq Tsai

    Endometriosis is a common gynecological disorder affecting women of reproductive age, often leading to chronic pain, reduced quality of life, and infertility. It is characterized by ectopic endometrial growth within a hypoxic peritoneal environment. Autophagy, a cellular recycling pathway, is elevated in ectopic lesions. However, how hypoxia regulates autophagy to drive lesion development remains unclear. We found that inhibition of autophagy with chloroquine reduced stromal cell growth under hypoxia. The microRNA miR-21-5p, previously shown to be elevated by hypoxia in ectopic lesions, was examined and found to target cell division cycle 25A (CDC25A). Overexpression of miR-21-5p suppressed CDC25A. Under hypoxia, yes-associated protein 1 (YAP1) nuclear accumulation increased miR-21-5p, which in turn further reduced CDC25A expression. Silencing CDC25A enhanced autophagic flux, whereas pharmacologic inhibition of YAP1 with verteporfin restored CDC25A and p62 in mouse lesions and reduced lesion size. Collectively, these findings demonstrate that hypoxia activates YAP1-driven miR-21-5p, which represses CDC25A to promote autophagy and sustain lesion survival, highlighting the miR-21-5p/CDC25A axis as a potential therapeutic target.


  • Zinc deficiency in bullous pemphigoid: predisposing factors, skin fragility and renal function impact

    by Min-Chia Tai, Jen-Yu Wang, Chao-Chun Yang, Shaw-Jenq Tsai, Chia-Bao Chu

    This study investigated serum zinc levels in patients with bullous pemphigoid (BP) and identified a high prevalence of zinc deficiency, particularly among those with low body mass index, chronic kidney disease and hypertension. Zinc supplementation was associated with improved renal function and reduced skin fragility, highlighting its potential therapeutic role in managing BP.


  • Open Access

    Corrigendum to Suppression of dual-specificity phosphatase–2 by hypoxia increases chemoresistance and malignancy in human cancer cells

    by Shih-Chieh Lin, Chun-Wei Chien, Jenq-Chang Lee, Yi-Chun Yeh, Keng-Fu Hsu, Yen-Yu Lai, Shao-Chieh Lin, Shaw-Jenq Tsai


  • Open Access

    Melanophilin-induced primary cilia promote pancreatic cancer metastasis

    by Yu-Ying Chao, Ruei-Ci Lin, Ping-Jui Su, Chu-An Wang, Ting-Yuan Tu, Ya-Chin Hou, Yi-Tzui Tsai, I-Chen Peng, Shaw-Jenq Tsai, Yan-Shen Shan, et al.

    Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant tumors because of its high metastatic ability. The glutamine (Gln)-deficient microenvironment contributes to PDAC metastasis; however, the underlying molecular mechanisms remain unclear. Here, we demonstrated that melanophilin (MLPH) promotes PDAC metastasis by inducing the regrowth of primary cilia. Using RNA sequencing, we found that MLPH was upregulated in Gln-deficient conditions. MLPH facilitated PDAC metastasis in vitro and in vivo. Clinically, high MLPH expression is positively correlated with metastasis and poor PDAC prognosis. MLPH localized to the centrosome and facilitated the regrowth of primary cilia. The primary ciliogenesis upregulated phospholipase C γ-1 (PLCG1) to promote PDAC metastasis. Interestingly, PLCG1 was localized to the primary cilia, and depletion of PLCG1 alleviated primary ciliogenesis, suggesting a feedforward role for PLCG1 in mediating primary ciliogenesis. Thus, our study revealed a novel function of the MLPH-primary cilia-PLCG1 axis in facilitating PDAC metastasis under Gln deficiency both in vitro and in vivo.


  • Top Cited Papers
    Open Access

    Progesterone resistance in endometriosis: A pathophysiological perspective and potential treatment alternatives

    by Hsiao‐Chien Tang, Ting‐Chien Lin, Meng‐Hsing Wu, Shaw‐Jenq Tsai

    Background: Endometriosis is a common gynecological disease affecting women of reproductive age. Patients with endometriosis frequently experience severe chronic pain and have higher chances to experience infertility. Progesterone resistance is a major problem that develops during the medical treatment of endometriosis, which often leads to treatment failure of hormonal therapies. Previous studies indicated that the dysregulation of progesterone receptors (PR) is the primary factor leading to progesterone resistance in endometriosis.Methods: This review article systematically reviewed and summarized findings extracted from previously published papers available on PubMed, encompassing both experimental studies and clinical trials.Main findings: Various determinants influencing PR expression in endometriosis have been identified, including the environmental toxins, microRNAs, cell signaling pathways, genetic mutations, and the pro‐inflammatory cytokines. The selective estrogen/progesterone receptor modulators have emerged as novel therapeutic approaches for treating endometriosis, offering potential improvements in overcoming progesterone resistance.Conclusion: Concerns and limitations persist despite the newly developed drugs. Therefore, studies on unraveling new therapeutic targets based on the molecular mechanisms of progesterone resistance is warranted for the development potential alternatives to overcome hormonal treatment failure in endometriosis.


  • Feel so bac: is Fusobacterium the suspect causing endometriosis?

    by Huan-Tzu Hou, Ting-Chien Lin, Meng-Hsing Wu, Shaw-Jenq Tsai


  • Aberrant expression of interleukin-17A in mast cells contributes to the pathogenesis of hidradenitis suppurativa

    by Chia-Bao Chu, Chao-Chun Yang, Yuan-Yu Hsueh, Po-Chuan Chen, Yi-Kai Hong, Yu-Yun Kuo, Shaw-Jenq Tsai

    Hidradenitis suppurativa significantly diminishes the quality of life for patients. Delayed diagnosis represents a significant challenge in effectively managing hidradenitis suppurativa. To identify and characterize the key mediator in hidradenitis suppurativa. Bioinformatic analysis of transcriptomic was applied to identify potential candidates contributing to the disease process of hidradenitis suppurativa. Skin samples from 40 patients with hidradenitis suppurativa, four with psoriasis, and 29 with normal skin were included. The expression of interleukin (IL)-17A was evaluated and compared among normal skin, psoriasis, and different stages of hidradenitis suppurativa samples by immunohistochemistry or dual-color immunofluorescence. In-vitro experiments and RNA-seq analysis were also conducted to validate the expression of IL-17A and its pathogenic effect in hidradenitis suppurativa. Transcriptomic database analyses identified IL-17 signaling as a potential contributor to hidradenitis suppurativa. In hidradenitis suppurativa, the predominant IL-17A+ cell population was identified as mast cells. IL-17A+ mast cell density was significantly elevated in hidradenitis suppurativa, especially in samples with advanced Hurley stages, compared with normal skin and psoriasis samples. The close contact between IL-17A+ mast cells and IL-17 receptor (IL-17RA)-expressing keratinocytes was demonstrated, along with the significant effects of IL-17A on keratinocyte cell proliferation and hidradenitis suppurativa pathogenic gene expression. Treatment with biologics (brodalumab or adalimumab) reduced the severity of the disease and the number of IL-17A+ mast cells in affected tissues. The presence of high-density IL-17A+ mast cells may serve as a valuable pathological marker for diagnosing hidradenitis suppurativa. Moreover, developing therapeutic drugs targeting IL-17A+ mast cells may provide a new approach to treating hidradenitis suppurativa.


  • Open Access

    Optogenetically engineered Ca2+ oscillation-mediated DRP1 activation promotes mitochondrial fission and cell death

    by Yi-Shyun Lai, Cheng-Chi Chang, Yong-Yi Chen, Thi My Hang Nguyen, Jixuan Xu, Ying-Chi Chen, Yu-Fen Chang, Chia-Yih Wang, Pai-Sheng Chen, Shih-Chieh Lin, et al.

    Mitochondrial dynamics regulate the quality and morphology of mitochondria. Calcium (Ca2+) plays an important role in regulating mitochondrial function. Here, we investigated the effects of optogenetically engineered Ca2+ signaling on mitochondrial dynamics. More specifically, customized illumination conditions could trigger unique Ca2+ oscillation waves to trigger specific signaling pathways. In this study, we found that modulating Ca2+ oscillations by increasing the light frequency, intensity and exposure time could drive mitochondria toward the fission state, mitochondrial dysfunction, autophagy and cell death. Moreover, illumination triggered phosphorylation at the Ser616 residue but not the Ser637 residue of the mitochondrial fission protein, dynamin-related protein 1 (DRP1, encoded by DNM1L), via the activation of Ca2+-dependent kinases CaMKII, ERK and CDK1. However, optogenetically engineered Ca2+ signaling did not activate calcineurin phosphatase to dephosphorylate DRP1 at Ser637. In addition, light illumination had no effect on the expression levels of the mitochondrial fusion proteins mitofusin 1 (MFN1) and 2 (MFN2). Overall, this study provides an effective and innovative approach to altering Ca2+ signaling for controlling mitochondrial fission with a more precise resolution than pharmacological approaches in the temporal dimension.